FDA Inspection
Lornamead Inc.Lornamead Inc. – FDA Inspection, Jan 21, 2026
Record Details
This FDA Inspection record concerns Lornamead Inc., with an inspection on January 21, 2026, issued by the New York District Office, covering human drugs.
View Company Profile
ID · bcb763f3-20c9-4064-b3e2-30128d5c4686
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1299288
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lornamead Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | Not classified | New York District Office | |
| April 11, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lornamead Inc.
- FDA Inspection 1263485 - 2025-06-05
- FDA Inspection 1202257 - 2023-04-11
- FDA Inspection 955642 - 2015-12-18
- FDA Inspection 836243 - 2013-06-07
- FDA Inspection 717989 - 2011-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.